Getagraph.com logo
S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(0.11%) $83.66
Gas
(-1.16%) $1.619
Gold
(0.30%) $2 349.60
Silver
(-0.43%) $27.52
Platinum
(0.42%) $924.40
USD/EUR
(0.32%) $0.935
USD/NOK
(0.67%) $11.02
USD/GBP
(0.13%) $0.800
USD/RUB
(-0.07%) $92.11

Realaus laiko atnaujinimai Immuneering Corporation [IMRX]

Birža: NASDAQ Sektorius: Healthcare Pramonė: Biotechnology
Upcoming Earnings Alert

4 days till quarter result
(bmo 2024-05-02)

Expected move: +/- 15.06%

Atnaujinta26 bal. 2024 @ 23:00
25% discount on Stockinvest.us - Use code: Podcast

2.80% $ 1.470

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):
Profile picture for Immuneering Corporation

Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to treat solid tumors...

Stats
Šios dienos apimtis 294 601
Vidutinė apimtis 707 925
Rinkos kapitalizacija 43.59M
EPS $0 ( 2024-03-04 )
Kita pelno data ( $-0.450 ) 2024-05-02
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.780
ATR14 $0.00400 (0.27%)
Insider Trading
Date Person Action Amount type
2024-04-01 Cormorant Asset Management, Lp Sell 100 Class A Common Stock
2024-04-01 Cormorant Asset Management, Lp Sell 300 Class A Common Stock
2024-04-01 Cormorant Asset Management, Lp Sell 100 Class A Common Stock
2024-04-01 Cormorant Asset Management, Lp Sell 600 Class A Common Stock
2024-04-01 Cormorant Asset Management, Lp Sell 10 Class A Common Stock
INSIDER POWER
6.63
Last 92 transactions
Buy: 3 241 516 | Sell: 1 367 921

Tūris Koreliacija

Ilgas: -0.24 (neutral)
Trumpas: -0.97 (very strong negative)
Signal:(37.764) Neutral

Immuneering Corporation Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
PAIC0.952
SVAC0.945
TIL0.941
BLPH0.933
FTOC0.932
TFFP0.929
LNSR0.928
SVOK0.927
FTOCU0.927
NRBO0.921
10 Labiausiai neigiamai susiję koreliacijos
NETE-0.972
MMAC-0.953
SASR-0.949
STIM-0.943
BSRR-0.942
HMST-0.94
ISTR-0.939
FNCB-0.939
IART-0.939
BOCH-0.934

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Immuneering Corporation Koreliacija - Valiuta/Žaliavos

The country flag -0.38
( neutral )
The country flag -0.20
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.04
( neutral )

Immuneering Corporation Finansinės ataskaitos

Annual 2023
Pajamos: $0
Bruto pelnas: $-764 138 (0.00 %)
EPS: $-1.880
FY 2023
Pajamos: $0
Bruto pelnas: $-764 138 (0.00 %)
EPS: $-1.880
FY 2022
Pajamos: $316 952
Bruto pelnas: $158 830 (50.11 %)
EPS: $-1.870
FY 2021
Pajamos: $2.08M
Bruto pelnas: $927 000 (44.57 %)
EPS: $-2.46

Financial Reports:

No articles found.

Immuneering Corporation

Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to treat solid tumors. The company also has five oncology programs in the discovery stage that are designed to target components of the MAPK or mTOR pathway; and two discovery stage neuroscience programs. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts. Immuneering Corporation was a former subsidiary of Teva Pharmaceutical Industries Limited.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.